NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Up 52.3% in February

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) saw a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 169,500 shares, a growth of 52.3% from the January 31st total of 111,300 shares. Currently, 10.8% of the company’s shares are sold short. Based on an average daily trading volume, of 2,710,000 shares, the days-to-cover ratio is presently 0.1 days.

NLS Pharmaceutics Trading Down 10.1 %

NASDAQ:NLSP opened at $1.60 on Wednesday. The company has a fifty day moving average of $2.06 and a 200 day moving average of $2.37. NLS Pharmaceutics has a 52 week low of $1.47 and a 52 week high of $18.39.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).